| Year |
Title |
Altmetric |
| 2019
|
Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.
Journal of Biological Chemistry.
294:15604-15612.
2019
|
|
| 2019
|
AP-1 and the injury response of the GFAP gene.
Journal of Neuroscience Research.
97:149-161.
2019
|
|
| 2016
|
Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.
Journal of Proteome Research.
15:2265-2282.
2016
|
|
| 2015
|
Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.
Glia.
63:2285-2297.
2015
|
|
| 2015
|
A new mutation in GFAP widens the spectrum of Alexander disease.
European Journal of Human Genetics.
23:1-2.
2015
|
|
| 2014
|
Changes in the morphology and proliferation of astrocytes induced by two modalities of chemically functionalized single-walled carbon nanotubes are differentially mediated by glial fibrillary acidic protein
2014
|
|
| 2014
|
Role of GFAP in CNS injuries.
Neuroscience Letters.
565:7-13.
2014
|
|
| 2013
|
Transgenic analysis of GFAP promoter elements.
Glia.
61:1488-1499.
2013
|
|
| 2012
|
Splice site, frameshift, and chimeric GFAP mutations in Alexander disease.
Human Mutation.
33:1141-1148.
2012
|
|
| 2012
|
Alexander disease
2012
|
|
| 2012
|
Archetypal and new families with Alexander disease and novel mutations in GFAP.
Archives of Neurology.
69:208-214.
2012
|
|
| 2010
|
Alteration Of glial-neuronal metabolic interactions in a mouse model of Alexander disease.
Glia.
58:1228-1234.
2010
|
|
| 2010
|
Drug screening to identify suppressors of GFAP expression.
Human Molecular Genetics.
19:3169-3178.
2010
|
|
| 2009
|
An infantile case of Alexander disease unusual for its MRI features and a GFAP allele carrying both the p.Arg79His mutation and the p.Glu223Gln coding variant.
Journal of Neurology.
256:679-682.
2009
|
|
| 2008
|
Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.
Journal of Gene Medicine.
10:583-592.
2008
|
|
| 2008
|
GFAP promoter elements required for region-specific and astrocyte-specific expression.
Glia.
56:481-493.
2008
|
|
| 2008
|
Adult-onset Alexander disease with progressive ataxia and palatal tremor.
Movement Disorders.
23:118-122.
2008
|
|
| 2006
|
Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice.
Journal of Clinical Neuroscience.
13:934-938.
2006
|
|
| 2006
|
Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Glia.
53:677-687.
2006
|
|
| 2006
|
Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
Journal of Neuroscience Research.
83:744-753.
2006
|
|
| 2006
|
Propensity for paternal inheritance of de novo mutations in Alexander disease.
Human Genetics.
119:137-144.
2006
|
|
| 2006
|
The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of αB-crystallin and HSP27.
American Journal of Human Genetics.
79:197-213.
2006
|
|
| 2005
|
Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP.
Journal of Cell Science.
118:2057-2065.
2005
|
|
| 2005
|
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.
Annals of Neurology.
57:310-326.
2005
|
|
| 2005
|
Unusual variants of Alexander's disease.
Annals of Neurology.
57:327-338.
2005
|
|
| 2004
|
Expression specificity of GFAP transgenes.
Neurochemical Research.
29:2075-2093.
2004
|
|
| 2004
|
Expression specificity of GFAP transgenes..
Neurochemical Research.
29:2075-2093.
2004
|
|
| 2004
|
Dominantly-inherited adult-onset leukodystrophy with palatal tremor caused by a mutation in the glial fibrillary acidic protein gene.
Movement Disorders.
19:1244-1248.
2004
|
|
| 2004
|
Expression of glial fibrillary acidic protein in primary cultures of human Müller cells.
Experimental Eye Research.
79:423-429.
2004
|
|
| 2003
|
Alexander's disease: Clinical, pathologic, and genetic features.
Journal of Child Neurology.
18:625-632.
2003
|
|
| 2003
|
GFAP: Functional implications gleaned from studies of genetically engineered mice.
Glia.
43:87-90.
2003
|
|
| 2003
|
Alexander disease: GFAP mutations unify young and old.
Lancet Neurology.
2:75.
2003
|
|
| 2002
|
GFAP mutations in Alexander disease.
International Journal of Developmental Neuroscience.
20:259-268.
2002
|
|
| 2002
|
ICP monitoring following bilateral carotid occlusion in GFAP-null mice
2002
|
|
| 2001
|
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
2001
|
|
| 2001
|
A novel mutation in glial fibrillary acidic protein gene in a patient with Alexander disease.
Neuroscience Letters.
312:71-74.
2001
|
|
| 2001
|
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.
Nature Genetics.
27:117-120.
2001
|
|
| 2001
|
Alexander disease: New insights from genetics.
Journal of Neuropathology and Experimental Neurology.
60:563-573.
2001
|
|
| 2001
|
Update on white matter genetic disorders (multiple letters) [2].
Pediatric Neurology.
25:347-348.
2001
|
|
| 2000
|
High susceptibility to cerebral ischemia in GFAP-null mice.
Journal of Cerebral Blood Flow and Metabolism.
20:1040-1044.
2000
|
|
| 2000
|
Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
Cancer Gene Therapy.
7:1120-1126.
2000
|
|
| 1999
|
Biosynthetic capacity of C6 cells engineered with a glial fibrillary acidic protein-tyrosine hydroxylase transgene.
Medical Science Research.
27:423-425.
1999
|
|
| 1999
|
Nonlethal detection of transgene expression in the CNS of founder mice
1999
|
|
| 1985
|
The role of enzyme sequestration in the regulation of the adenylate cyclase of Dictyostelium discoideum.
Journal of Biological Chemistry.
260:3613-3616.
1985
|
|
| 1984
|
Transmembrane signaling in Dictyostelium discoideum: A possible mechanism.
The FASEB Journal.
43.
1984
|
|
| 1983
|
Forskolin does not activate cyclic AMP synthesis in Dictyostelium discoideum in vivo or in vitro.
Journal of cyclic nucleotide and protein phosphorylation research.
9:297-303.
1983
|
|
